Vanda Pharmaceuticals
VNDA
#8815
Rank
โ‚ฌ0.20 B
Marketcap
3,39ย โ‚ฌ
Share price
-6.42%
Change (1 day)
-10.12%
Change (1 year)

Earnings for Vanda Pharmaceuticals (VNDA)

Earnings in 2026 (TTM): -โ‚ฌ0.17 Billion

According to Vanda Pharmaceuticals's latest financial reports the company's current earnings are โ‚ฌ0.21 Billion. In 2025 the company made an earning of -โ‚ฌ0.14 Billion a decrease over its 2024 earnings that were of -โ‚ฌ36.36 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vanda Pharmaceuticals from 2005 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚ฌ0.17 Billion18.59%
2025 -โ‚ฌ0.14 Billion271.79%
2024 -โ‚ฌ36.36 Million191.43%
2023 -โ‚ฌ12.48 Million-320.45%
2022 โ‚ฌ5.65 M-84.99%
2021 โ‚ฌ37.7 M54.8%
2020 โ‚ฌ24.35 M19.42%
2019 โ‚ฌ20.39 M4.93%
2018 โ‚ฌ19.43 M-228.6%
2017 -โ‚ฌ15.12 Million-8.98%
2016 -โ‚ฌ16.61 Million-53.79%
2015 -โ‚ฌ35.94 Million-30.18%
2014 -โ‚ฌ51.47 Million173.08%
2013 -โ‚ฌ18.85 Million-25.33%
2012 -โ‚ฌ25.24 Million163.61%
2011 -โ‚ฌ9.58 Million-221.15%
2010 โ‚ฌ7.9 M-124.53%
2009 -โ‚ฌ32.23 Million-29.44%
2008 -โ‚ฌ45.67 Million-36.2%
2007 -โ‚ฌ71.58 Million21.81%
2006 -โ‚ฌ58.76 Million170.55%
2005 -โ‚ฌ21.72 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ23.43 B-14,215.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚ฌ13.88 B-8,459.99%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚ฌ6.17 B-3,820.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ30.04 B-18,194.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ6.87 B-4,241.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ10.65 B-6,514.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
-โ‚ฌ2.51 Million-98.49%๐Ÿ‡บ๐Ÿ‡ธ USA